{"symbol":"PFE","fiscalQuarter":"Q4-2017","reportDate":"2018-01-30","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q4-2017","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 3.13%","keyNumbers":[{"metric":"EPS","actual":"$0.62","expected":"N/A","surprise":"+6.19%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in R&D as a priority.","They noted the importance of maintaining strong product pipelines.","There was a focus on future opportunities in emerging markets."],"summary":"Management expressed a cautious optimism about future growth driven by R&D investments. They emphasized the need to strengthen their product pipeline."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.13%, likely due to the lack of revenue details and guidance, which may have raised concerns among investors about future performance.","metaDescription":"Pfizer Inc (PFE) Q4 2017 earnings: EPS beat expectations. Stock down 3.13%. Full breakdown."}}